BrainFx, a wholly owned subsidiary of Highmark Interactive, announced on October 5, its collaboration with Mayo Clinicto launch a COVID-19 Cognitive Recovery Tracker to better understand and assess the impact of “Long COVID” or “Post-COVID-19 Syndrome” on cognitive function over time.